Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

D-Dimer for Long-Term Risk Prediction in Patients After Acute Coronary Syndrome.

Kyrle PA, Eichinger S.

Circulation. 2018 Aug 14;138(7):724-726. doi: 10.1161/CIRCULATIONAHA.118.033670. No abstract available.

PMID:
30359138
2.

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.

Scheres L, Brekelmans M, Ageno W, Ay C, Büller HR, Eichinger S, Hutten BA, Klok FA, Middeldorp S, Schreiber K, Stach K, Blondon M, Delluc A.

BJOG. 2018 Nov;125(12):1581-1589. doi: 10.1111/1471-0528.15388. Epub 2018 Jul 20.

3.

Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial.

Traby L, Kaider A, Kollars M, Eichinger S, Wolzt M, Kyrle PA.

Thromb Res. 2018 May 17;167:149-155. doi: 10.1016/j.thromres.2018.05.021. [Epub ahead of print]

PMID:
29857271
4.

Early Degeneration Caused by Cusp Tear of First-Generation Trifecta Bioprosthesis.

Eichinger S, Badreldin AMA, Eichinger WB.

Ann Thorac Surg. 2018 Dec;106(6):e297-e298. doi: 10.1016/j.athoracsur.2018.03.063. Epub 2018 Apr 30.

PMID:
29723533
5.

Risk of venous thromboembolism during rehabilitation of patients with spinal cord injury.

Eichinger S, Eischer L, Sinkovec H, Wittgruber G, Traby L, Kammer M, Kyrle PA, Steinbrecher O, Kaloud H, Kyrle V, Moser H, Wildburger R.

PLoS One. 2018 Mar 28;13(3):e0193735. doi: 10.1371/journal.pone.0193735. eCollection 2018.

6.

High proportion of patients with bleeding of unknown cause in persons with a mild-to-moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB).

Gebhart J, Hofer S, Panzer S, Quehenberger P, Sunder-Plassmann R, Hoermann G, Eigenbauer E, Haslacher H, Kepa S, Kyrle PA, Eichinger S, Knöbl P, Eischer L, Mannhalter C, Ay C, Pabinger I.

Haemophilia. 2018 May;24(3):405-413. doi: 10.1111/hae.13422. Epub 2018 Feb 1.

PMID:
29388750
7.

Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.

Eichinger S, Kyrle PA, Kammer M, Eischer L, Ozsvar Kozma M, Binder CJ.

J Thromb Haemost. 2018 Jan;16(1):31-35. doi: 10.1111/jth.13874. Epub 2017 Nov 8.

PMID:
29045005
8.

Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.

Khan F, Rahman A, Carrier M, Kearon C, Schulman S, Couturaud F, Prandoni P, Eichinger S, Becattini C, Agnelli G, Büller HR, Brighton TA, Palareti G, Pinede L, Sabri E, Hutton B, Wells GA, Rodger MA; MARVELOUS Collaborators.

BMJ Open. 2017 Sep 21;7(9):16950. doi: 10.1136/bmjopen-2017-016950. Review.

9.

Risk of cancer after anticoagulation in patients with unprovoked venous thromboembolism: an observational cohort study.

Eischer L, Kammer M, Traby L, Kyrle PA, Eichinger S.

J Thromb Haemost. 2017 Jul;15(7):1368-1374. doi: 10.1111/jth.13702. Epub 2017 May 18.

PMID:
28407356
10.

Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey.

Klok FA, Schreiber K, Stach K, Ageno W, Middeldorp S, Eichinger S, Delluc A, Blondon M, Ay C.

Thromb Res. 2017 May;153:101-107. doi: 10.1016/j.thromres.2017.03.013. Epub 2017 Mar 20. Review.

PMID:
28376343
11.

Reversing vitamin K antagonists: making the old new again.

Eichinger S.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):605-611. Review.

12.

The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.

Kyrle PA, Kammer M, Eischer L, Weltermann A, Minar E, Hirschl M, Heinze G, Eichinger S.

J Thromb Haemost. 2016 Dec;14(12):2402-2409. doi: 10.1111/jth.13524. Epub 2016 Nov 19.

13.

Cancer associated thrombosis: risk factors and outcomes.

Eichinger S.

Thromb Res. 2016 Apr;140 Suppl 1:S12-7. doi: 10.1016/S0049-3848(16)30092-5. Review.

PMID:
27067965
14.

Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism.

Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes RD, McBane RD, Moll S, Ansell J.

J Thromb Thrombolysis. 2016 Apr;41(3):548. doi: 10.1007/s11239-016-1345-4. No abstract available.

15.

The European Hematology Association Roadmap for European Hematology Research: a consensus document.

Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, de Wit TD, Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ; EHA Roadmap for European Hematology Research.

Haematologica. 2016 Feb;101(2):115-208. doi: 10.3324/haematol.2015.136739. Epub 2016 Jan 27.

16.

Guidance for the treatment of deep vein thrombosis and pulmonary embolism.

Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R, McBane RD, Moll S, Ansell J.

J Thromb Thrombolysis. 2016 Jan;41(1):32-67. doi: 10.1007/s11239-015-1317-0. Review. Erratum in: J Thromb Thrombolysis. 2016 Apr;41(3):548.

17.

Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects.

Traby L, Kollars M, Kaider A, Eichinger S, Wolzt M, Kyrle PA.

J Thromb Haemost. 2016 Feb;14(2):273-81. doi: 10.1111/jth.13216. Epub 2016 Jan 30.

18.

Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data.

Marcucci M, Iorio A, Douketis JD, Eichinger S, Tosetto A, Baglin T, Cushman M, Palareti G, Poli D, Tait RC, Kyrle PA.

J Thromb Haemost. 2015 May;13(5):775-81. doi: 10.1111/jth.12871. Epub 2015 Mar 12.

19.

Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects.

Weisshaar S, Litschauer B, Gouya G, Mayer P, Smerda L, Kapiotis S, Kyrle PA, Eichinger S, Wolzt M.

J Thromb Haemost. 2014 Nov;12(11):1850-60. doi: 10.1111/jth.12726. Epub 2014 Oct 16.

20.

Dabigatran: patient management in specific clinical settings.

Kyrle PA, Binder K, Eichinger S, Függer R, Gollackner B, Hiesmayr JM, Huber K, Lang W, Perger P, Quehenberger P, Roithinger FX, Schmaldienst S, Weltermann A, Domanovits H.

Wien Klin Wochenschr. 2014 Sep;126(17-18):503-8. doi: 10.1007/s00508-014-0581-x. Epub 2014 Aug 20.

21.

Oral anticoagulation and vitamin K deficiency.

Eichinger S.

Hamostaseologie. 2014;34(3):237-8. doi: 10.5482/HAMO-14-03-0019. Epub 2014 Jun 12.

PMID:
24919584
22.

The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study.

Eischer L, Eichinger S, Kyrle PA.

J Thromb Haemost. 2014 May;12(5):635-40. doi: 10.1111/jth.12528.

23.

D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model.

Eichinger S, Heinze G, Kyrle PA.

J Am Heart Assoc. 2014 Jan 2;3(1):e000467. doi: 10.1161/JAHA.113.000467.

24.

[Recurrent venous thrombosis].

Eichinger S, Schellong S.

Hamostaseologie. 2013 Aug 1;33(3):191. German. No abstract available.

PMID:
23903492
25.

Anticoagulation after venous thromboembolism. Deciding on the optimal duration.

Eichinger S.

Hamostaseologie. 2013 Aug 1;33(3):211-7. doi: 10.5482/HAMO-13-03-0015. Epub 2013 May 29.

PMID:
23719863
26.

Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences.

Marcucci M, Smith CT, Douketis JD, Tosetto A, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.

J Clin Epidemiol. 2013 Apr;66(4):415-25. doi: 10.1016/j.jclinepi.2012.08.007. Epub 2013 Feb 8.

PMID:
23395515
27.

Prediction of recurrent venous thromboembolism by clot lysis time: a prospective cohort study.

Traby L, Kollars M, Eischer L, Eichinger S, Kyrle PA.

PLoS One. 2012;7(12):e51447. doi: 10.1371/journal.pone.0051447. Epub 2012 Dec 11.

28.

Clinical presentation of venous thromboembolism in inflammatory bowel disease.

Papay P, Miehsler W, Tilg H, Petritsch W, Reinisch W, Mayer A, Haas T, Kaser A, Feichtenschlager T, Fuchssteiner H, Knoflach P, Vogelsang H, Platzer R, Tillinger W, Jaritz B, Schmid A, Blaha B, Dejaco C, Sobala A, Weltermann A, Eichinger S, Novacek G.

J Crohns Colitis. 2013 Oct;7(9):723-9. doi: 10.1016/j.crohns.2012.10.008. Epub 2012 Nov 3.

PMID:
23127785
29.

Clinical scores to predict recurrence risk of venous thromboembolism.

Kyrle PA, Eichinger S.

Thromb Haemost. 2012 Dec;108(6):1061-4. doi: 10.1160/TH12-05-0353. Epub 2012 Aug 7. Review.

PMID:
22872143
30.

Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study.

Eischer L, Tscholl V, Heinze G, Traby L, Kyrle PA, Eichinger S.

PLoS One. 2012;7(6):e38705. doi: 10.1371/journal.pone.0038705. Epub 2012 Jun 6.

31.

Medical therapy in venous thromboembolism.

Eichinger S, Kyrle PA.

Semin Respir Crit Care Med. 2012 Apr;33(2):186-90. doi: 10.1055/s-0032-1311797. Epub 2012 May 30.

PMID:
22648491
32.

Aspirin for preventing the recurrence of venous thromboembolism.

Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P; WARFASA Investigators.

N Engl J Med. 2012 May 24;366(21):1959-67. doi: 10.1056/NEJMoa1114238. Erratum in: N Engl J Med. 2012 Oct 18;367(16):1573.

33.

Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).

Tosetto A, Iorio A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Douketis J.

J Thromb Haemost. 2012 Jun;10(6):1019-25. doi: 10.1111/j.1538-7836.2012.04735.x.

34.

Duration of anticoagulation after venous thrombosis.

Eichinger S, Kyrle PA.

Vasa. 2012 Jan;41(1):11-7. doi: 10.1024/0301-1526/a000158. Review.

PMID:
22247055
35.

Vitamin K antagonists: self-determination by self-monitoring?

Kyrle PA, Eichinger S.

Lancet. 2012 Jan 28;379(9813):292-3. doi: 10.1016/S0140-6736(11)61748-0. Epub 2011 Nov 30. No abstract available.

PMID:
22137797
37.

Risk assessment for recurrent venous thrombosis.

Kyrle PA, Rosendaal FR, Eichinger S.

Lancet. 2010 Dec 11;376(9757):2032-9. doi: 10.1016/S0140-6736(10)60962-2. Epub 2010 Dec 3. Review.

PMID:
21131039
38.

Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.

Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.

Ann Intern Med. 2010 Oct 19;153(8):523-31. doi: 10.7326/0003-4819-153-8-201010190-00009. Review.

PMID:
20956709
39.

ProCGlobal and endogenous thrombin potential during pregnancy.

Hron G, Kyrle PA, Kaider A, Philipp K, Pabinger I, Kollars M, Eichinger S.

Am J Obstet Gynecol. 2010 Nov;203(5):463.e1-6. doi: 10.1016/j.ajog.2010.05.034. Epub 2010 Jul 3.

PMID:
20598285
40.

Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.

Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, Mayer A, Haas T, Kaser A, Feichtenschlager T, Fuchssteiner H, Knoflach P, Vogelsang H, Miehsler W, Platzer R, Tillinger W, Jaritz B, Schmid A, Blaha B, Dejaco C, Eichinger S.

Gastroenterology. 2010 Sep;139(3):779-87, 787.e1. doi: 10.1053/j.gastro.2010.05.026. Epub 2010 Jun 12.

PMID:
20546736
41.

The effects of low-molecular-weight heparin at two different dosages on thrombin generation in cancer patients. A randomised controlled trial.

Traby L, Kaider A, Schmid R, Kranz A, Quehenberger P, Kyrle PA, Eichinger S.

Thromb Haemost. 2010 Jul;104(1):92-9. doi: 10.1160/TH09-12-0863. Epub 2010 May 10.

PMID:
20458441
42.

Peri-interventional control of haemostasis in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma - a rare indication for recombinant factor VIIa.

Lechner D, Eichinger S, Wanivenhaus A, Kyrle PA.

Haemophilia. 2010 Jul 1;16(4):704-5. doi: 10.1111/j.1365-2516.2010.02240.x. Epub 2010 Apr 12. No abstract available.

PMID:
20398074
43.

Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.

Eichinger S, Heinze G, Jandeck LM, Kyrle PA.

Circulation. 2010 Apr 13;121(14):1630-6. doi: 10.1161/CIRCULATIONAHA.109.925214. Epub 2010 Mar 29.

PMID:
20351233
44.

Age at first venous thromboembolism and risk of recurrence: a prospective cohort study.

Eischer L, Eichinger S, Kyrle PA.

Medicine (Baltimore). 2009 Nov;88(6):366-70. doi: 10.1097/MD.0b013e3181c29e31.

45.

[Perioperative thromboprophylaxis in adults].

Eichinger S.

Wien Med Wochenschr. 2009 Oct;159(19-20):475-80. doi: 10.1007/s10354-009-0711-7. Review. German.

PMID:
19898786
46.

Is Virchow's triad complete?

Kyrle PA, Eichinger S.

Blood. 2009 Aug 6;114(6):1138-9. doi: 10.1182/blood-2009-05-223511. No abstract available.

47.

Duration of anticoagulation after initial idiopathic venous thrombosis--the swinging pendulum: risk assessment to predict recurrence.

Eichinger S, Kyrle PA.

J Thromb Haemost. 2009 Jul;7 Suppl 1:291-5. doi: 10.1111/j.1538-7836.2009.03383.x. Review.

48.

Mechanisms underlying acquired von Willebrand syndrome associated with an IgM paraprotein.

Mayerhofer M, Haushofer A, Kyrle PA, Chott A, Müllner C, Quehenberger P, Worel N, Traby L, Eichinger S.

Eur J Clin Invest. 2009 Sep;39(9):833-6. doi: 10.1111/j.1365-2362.2009.02177.x. Epub 2009 Jul 1.

PMID:
19572993
49.

Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa.

Eichinger S, Lubsczyk B, Kollars M, Traby L, Zwiauer K, Gleiss A, Quehenberger P, Kyrle PA.

Eur J Clin Invest. 2009 Aug;39(8):707-13. doi: 10.1111/j.1365-2362.2009.02168.x. Epub 2009 May 26.

PMID:
19490067
50.

Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudin.

Eslam RB, Reiter N, Kaider A, Eichinger S, Lang IM, Panzer S.

Eur Heart J. 2009 Aug;30(15):1831-6. doi: 10.1093/eurheartj/ehp186. Epub 2009 May 24.

PMID:
19468011

Supplemental Content

Loading ...
Support Center